Oxford Innovation has been appointed by the Welsh Government to deliver a new programme that will assist start-up and early stage life sciences firms with high growth potential to grow more rapidly over the next three years.
SQW Ltd

SQW is a leading economic & management consultancy based in Cambridge, Edinburgh, Leeds, Manchester, London and Hong Kong. Our core skills lie in delivering practical policy and management solutions in science & technology, education, SME support, and regional development.
SQW was founded in 1983. Consultants are drawn from academia, government, industry and the development agencies. Our clients include international bodies, such as the World Bank and the European Commission, government departments in the UK and overseas, several directorates of the European Commission, major charitable foundations, private firms and a wide range of regional development agencies and local authorities. Our HQ is in Cambridge and our other offices are in Edinburgh, London, Leeds, Manchester and Hong Kong.
The firm's skill base centres on wealth creation and the ways in which it may be enhanced through policies, programmes and projects at national, regional and local levels. Many of our staff have economics or related qualifications, but we also employ staff whose degrees were in scientific or other disciplines. Senior staff typically have wide experience of strategy development and review, feasibility and evaluation assignments and there is also a specialist capability in performance measurement. They are supported by research consultants, who assist in surveys, data assembly and analysis.
In terms of subject matter SQW has a distinctive strength in relation to the organisation and effectiveness of research policies and programmes. This links across to the commercialisation of research through technology transfer and new firm starts. We have also undertaken a range of work exploring the, currently fashionable, topic of clusters and recently published a new book on the Cambridge Phenomenon. SQW also has a strong record in working across the range of tasks being developed by the UK Regional Development Agencies, drawing on our strengths in SME development, skills, strategic planning, programme review and the design of performance measurement and monitoring systems.
There are no Products & Services to display
Oxford Investment Opportunity Network (OION), Europe’s leading technology business angel network, is to participate in the Business Angel Co-investment Fund (Angel CoFund) announced by the government that will provide £50 million to invest in high growth companies alongside business angels.
Scott Bader Innovation Centre in Northamptonshire was officially launched last week as part of the Global Entrepreneurship Week celebrations, with the first occupier set to move in next month.
Adaptimmune, which is pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.
Harborough Innovation Centre, designed as a hub for local businesses to launch, innovate and grow, has welcomed its first occupiers. Four companies have moved into office premises at the Centre and one of the businesses is Sporting Edge which was set up by former Leicestershire and England cricketer Jeremy Snape.
Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. The Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.
Scott Bader has announced that it is creating an innovation centre for start-up companies in the specialty chemicals, composites and coatings sectors. Opening on 1 July, Scott Bader Innovation Centre will provide shared laboratory space and high quality offices on the company’s state-of-the-art R&D headquarters site at Wollaston, Northamptonshire.
The Market Harborough Innovation and Business Centre, which will be a hub for local businesses to launch, innovate and grow, has been officially handed over by developer William Davis Ltd to Harborough District Council. The ceremony also marked the formal appointment of Oxford Innovation to manage the Innovation Centre.
Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.
Oxford Investment Opportunity Network (OION), Europe’s leading technology business angel network, has welcomed the Government’s announcement of the Regional Growth Fund which looks likely to provide £50 million for the development of a national fund to invest in high growth start-ups alongside business angels.
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, today announced that it has strengthened its Board with the appointment of medical industry veteran, Bill Moffitt, as Chairman and Peter Whitehouse as CFO.
TiE UK (The Indus Entrepreneurs) has announced the shortlist of student teams who will pitch their business plans to a panel of some of the UK’s leading entrepreneurs and venture capitalists at the TiE Young Entrepreneurs Awards on Wednesday 30 March in London.
Innovators and entrepreneurs across Oxfordshire and surrounding areas are urged to enter The Martin & Audrey Wood Enterprise Awards 2011, which are launched today. The awards offer fantastic opportunities for companies to gain recognition for their achievements and raise their profile within the local business community.
Adaptimmune Limited today announced that it has launched a US subsidiary, Adaptimmune LLC, located in Philadelphia, and appointed Dr Gwen Binder-Scholl as Vice President of Operations of the new company.
Science Oxford has announced today that it is creating a new innovation centre to support entrepreneurs and start-up companies. Due to open in March, the 25,000 sq ft innovation centre is part of a site in the heart of the city of Oxford.
Fusion research company Tokamak Solutions has secured £170,000 of equity investment from Sir Martin and Lady Audrey Wood, the Rainbow Seed Fund, Oxford Instruments plc and investor members of the Oxford Early Investments network.
Oxford Early Investments, a leading investment network that helps early stage companies to secure funding from investors, has announced the appointment of Chris Baker as its new manager.
SQW is undertaking research for the Department for Business, Innovation and Skills, and are holding a focus group at St John's Innovation Centre on 7th October to get business perspectives on business information and advice.
Oxford Investment Opportunity Network (OION), Europe’s leading technology investment network, has announced the signing of the Harwell Science and Innovation Campus as a major new sponsor on a deal that is intended to boost the links between high growth companies, investors and research organisations in Oxfordshire.
Aeristech Ltd, a developer of novel, turbocharger technology which significantly enhances fuel efficiency in vehicle engines while reducing emissions, has secured £500,000 with help from Oxford Investment Opportunity Network (OION), Europe’s leading technology investment network.
Pages
There are no events to display
There are no jobs to display
No Blog articles found